News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) And Johnson & Johnson (JNJ) Give Each Other Headaches Over An Advil Ad


7/3/2014 8:13:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The executives at Pfizer PFE -0.07% and Johnson & Johnson JNJ -0.32% are giving each other headaches over an ad for a widely used pain reliever.

Here’s the story: Last fall, the J&J McNeil unit, which sells Tylenol and other over-the-counter medicines, objected to an ad in several medical journals for a pediatric form of Advil, a rival product sold by Pfizer. The McNeil team demanded Pfizer immediately yank its ad on the grounds that it violated a 1989 court order preventing ads that suggest an infant form Advil is “like” or “comparable” to Tylenol for infants.

Help employers find you! Check out all the jobs and post your resume.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES